Conditions: Metastatic Soft Tissue Sarcoma
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 209
Healthy volunteers: no

Brief summary:
This study is being done to see if MORAb-004 increases the effectiveness of the chemotherapies gemcitabine and docetaxel in people with metastatic Soft Tissue Sarcoma.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: MORAb-004 intervention 2: Gemcitabine intervention 3: Docetaxel intervention 4: Gemcitabine intervention 5: Docetaxel intervention 6: Placebo
Intervention descriptions: intervention 1: IV, Days 1 and 8 of every cycle until disease progression intervention 2: IV, Days 1 and 8 of each cycle until disease progression intervention 3: IV, Day 8 of every cycle until disease progression intervention 4: IV, Days 1 and 8 of each cycle until disease progression intervention 5: IV, Day 8 of every cycle until disease progression intervention 6: None

Protocol document: